United Kingdom · Question · Written question
UIN 803
Mast Cell Activation Syndrome: Health Services
Original
Introduced
13 May 2026
Last action
30 June 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
30 June 2026
Summary
To ask the Secretary of State for Health and Social Care, what guidance is provided to NHS Trusts on the diagnosis and management of Mast Cell Activation Syndrome in the absence of traditional allergy markers.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
13 May 2026
Written question
To ask the Secretary of State for Health and Social Care, what guidance is provided to NHS Trusts on the diagnosis and management of Mast Cell Activation Syndrome in the absence of traditional allergy markers.
Source: Commons
30 June 2026
Answer
There is currently no National Institute for Health and Care Excellence (NICE) clinical guideline specifically covering the diagnosis and management of mast cell activation syndrome (MCAS). In the absence of condition‑specific national guidance, clinician...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-05-13/803
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1904881
- uk · wq-1904881 · source updated 30 June 2026